The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease. (Record no. 23993696)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02125 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516222603.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201506s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2567-689X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1160/TH13-10-0891 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gurbel, P A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20150615 |
| 245 00 - TITLE STATEMENT | |
| Title | The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Thrombosis and haemostasis |
| Date of publication, distribution, etc. | Sep 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 589-97 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Protocols |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clopidogrel |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Coronary Artery Disease |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytochrome P-450 CYP2C19 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperazines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Platelet Aggregation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Platelet Aggregation Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polymorphism, Genetic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prasugrel Hydrochloride |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thiophenes |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ticlopidine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bergmeijer, T O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tantry, U S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | ten Berg, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Angiolillo, D J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | James, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lindahl, T L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Svensson, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jakubowski, J A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brown, P B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Duvvuru, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sundseth, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Walker, J R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Small, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moser, B A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Winters, K J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Erlinge, D |
| 773 0# - HOST ITEM ENTRY | |
| Title | Thrombosis and haemostasis |
| Related parts | vol. 112 |
| -- | no. 3 |
| -- | p. 589-97 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1160/TH13-10-0891">https://doi.org/10.1160/TH13-10-0891</a> |
| Public note | Available from publisher's website |
No items available.